'Sales of new homes down 18% in June'

Central Bureau of Statistics: Housing demand fell 27% in June, and supply was up.

By ADI BEN-ISRAEL/GLOBES
August 1, 2011 12:15
New-build apartment in Netanya

Netanya apartment 311. (photo credit: Avi Sasa )

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

There were 1,441 new home sales in June 2011, 18 percent fewer than in May, and 18.6% fewer than in June 2010, the Central Bureau of Statistics reported on Sunday. This was the lowest number of sales since January 2009.

Demand for new homes totaled 2,427 homes in June, 27% less than in May and 31% less than in June last year. This was the lowest level since October 2008.

Be the first to know - Join our Facebook page.


Supply of new homes rose for the fourth consecutive month to 11,929 homes in June from 11,726 in May, an increase of 1.7%. This was the highest level since September 2007. Housing inventory, at the current sales pace, is sufficient for eight months, up from 7.8 months in May.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS